Vol.:(0123456789)1 3
Rheumatology International (2018) 38:319 https://doi.org/10.1007/s00296-017-3918-8
CORRECTION
Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety
Milena A. Gianfrancesco1 · Gabriela Schmajuk1,2 · Sarah Haserodt3 · Laura Trupin1 · Zara Izadi4 · Kashif Jafri1 · Stephen Shiboski4 · Marina Sirota5 · R. Adams Dudley6 · Jinoos Yazdany1
Published online: 22 December 2017 © Springer-Verlag GmbH Germany, part of Springer Nature 2017
Correction to: Rheumatol Int (2017) 37:1611–1618 https://doi.org/10.1007/s00296‑017‑3782‑6
The given and family name of a co-author R. Adams Dud-ley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.
RheumatologyINTERNATIONAL
The original article can be found online at https://doi.org/10.1007/s00296-017-3782-6.
* Milena A. Gianfrancesco [email protected]
Gabriela Schmajuk [email protected]
Sarah Haserodt [email protected]
Laura Trupin [email protected]
Zara Izadi [email protected]
Kashif Jafri [email protected]
Stephen Shiboski [email protected]
Marina Sirota [email protected]
R. Adams Dudley [email protected]
Jinoos Yazdany [email protected]
1 Division of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
2 Veterans Affairs Medical Center, San Francisco, San Francisco, USA
3 Department of Medicine, California Pacific Medical Center, San Francisco, USA
4 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, USA
5 Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, USA
6 Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA
Recommended
